Recombinant Diazepam Binding Inhibitor (DBI)

Recombinant Human Diazepam Binding Inhibitor (DBI) is a purified Prokaryotic Protein. Purity: >97% by SDS-PAGE. Host: E. coli. Endotoxin Level: <1.0EU per 1ug, by the LAL method. Species: Human (Homo sapiens). Target Name: Diazepam Binding Inhibitor (DBI). Target Synonyms: ACBP; ACBD1; CCK-RP; EP; Endozepine; GABA Receptor Modulator; Acyl-Coenzyme A Binding Protein. Accession Number: P07108. Gene ID: 1622. Expression Region: Met1~Ile104. Tag Info: N-terminal His Tag. Theoretical MW: 20kDa. Buffer: PBS, pH7.4, containing 0.01% SKL, 5% Trehalose. Storage: -20°C. Avoid repeated freeze/thaw cycles. Restrictions: For Research Use Only. Not for use in diagnostic procedures.